相关实验视频
Updated: Jan 9, 2026

05:57
Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
699
腹部按摩对便秘患者的科学证据影响:叙述性审查
G Durga1, A Mooventhan2, R Gowthami3
1Department of Naturopathy, Government Yoga and Naturopathy Medical College, Chennai, Tamil Nadu, India.
International journal of therapeutic massage & bodywork
|December 8, 2025
概括
腹部按摩是一种简单,具有成本效益的疗法,可以有效地减少成人和老年人的便秘严重程度. 这种非药理学方法为胃肠道和息治疗患者提供了显著的好处.
科学领域:
- 胃肠病学 胃肠病学
- 综合医学是一个整体医学.
- 基于证据的实践.
背景情况:
- 便秘是一种广泛存在的健康问题,会造成严重的身体和情绪痛苦.
- 对于便秘管理,越来越多地探索非药物疗法.
- 腹部按摩是一种潜在的简单而有效的干预.
研究的目的:
- 审查关于腹部按摩治疗便秘的疗效的科学文献.
- 评估腹部按摩在不同人群和疾病中的影响.
- 评估腹部按摩的简单性,有效性和成本效益.
主要方法:
- 使用PubMed和PubMed Central进行了系统的文献搜索.
- 最初对246篇文章进行了相关性选.
- 在最终审查中,包括了33篇符合条件的文章.
主要成果:
- 腹部按摩在减少便秘严重程度方面表现出有效性.
- 在成人和老年人群中观察到好处.
- 在胃肠道,肌肉骨,神经系统疾病和息护理方面注意到了积极的影响.
结论:
- 腹部按摩是一种科学支持的,基于证据的便秘干预措施.
- 它提供了一个简单,有效和潜在的成本效益的管理选项.
- 进一步的研究可能会巩固其在临床实践中的作用.
更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
680
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
680
Assessment of the Rectum and Anus
1.0K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.0K
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
510
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
510
Drugs Affecting GI Tract Motility: Other Laxatives
992
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
992
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
857
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
857
Drugs for Treatment of Diarrhea-Predominant IBS
599
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
599

